Loading...

Intellectia LogoIntellectia
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. LGHT
LGHT logo

LGHT Valuation

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • AI Stock Picker
  • Swing Trading
  • SwingMax Portfolio
  • QuantAI Alpha Pick
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • Financial AI Agent
  • AI Screener
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Performance Decomposition

AI Analysis
1Y
3Y
5Y
Market capitalization of LGHT increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00% to the performance.
Overall, the performance of LGHT in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is LGHT currently overvalued or undervalued?

Langar Global HealthTech ETF (LGHT) is now in the Fair zone, suggesting that its current forward PS ratio of NaN is considered Fairly compared with the five-year average of --. The fair price of Langar Global HealthTech ETF (LGHT) is between -- to -- according to relative valuation method.

What is Langar Global HealthTech ETF (LGHT) fair value?

LGHT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Langar Global HealthTech ETF (LGHT) is between -- to -- according to relative valuation method.

How does LGHT's valuation metrics compare to the industry average?

The average P/S ratio for LGHT's competitors is 0.00, providing a benchmark for relative valuation. Langar Global HealthTech ETF Corp (LGHT) exhibits a P/S ratio of --, which is 0% above the industry average. Given its robust revenue growth of 0%, this premium appears unsustainable.

What is the current P/B ratio for Langar Global HealthTech ETF (LGHT) as of Mar 05 2026?

As of Mar 05 2026, Langar Global HealthTech ETF (LGHT) has a P/B ratio of NaN. This indicates that the market values LGHT at NaN times its book value.

What is the current FCF Yield for Langar Global HealthTech ETF (LGHT) as of Mar 05 2026?

As of Mar 05 2026, Langar Global HealthTech ETF (LGHT) has a FCF Yield of NaN%. This means that for every dollar of Langar Global HealthTech ETF's market capitalization, the company generates NaN cents in free cash flow.

What is the current Forward P/E ratio for Langar Global HealthTech ETF (LGHT) as of Mar 05 2026?

As of Mar 05 2026, Langar Global HealthTech ETF (LGHT) has a Forward P/E ratio of NaN. This means the market is willing to pay $NaN for every dollar of Langar Global HealthTech ETF's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Langar Global HealthTech ETF (LGHT) as of Mar 05 2026?

As of Mar 05 2026, Langar Global HealthTech ETF (LGHT) has a Forward P/S ratio of NaN. This means the market is valuing LGHT at $NaN for every dollar of expected revenue over the next 12 months.